213 related articles for article (PubMed ID: 25695249)
1. Interferon-gamma promotes infection of astrocytes by Trypanosoma cruzi.
Silva RR; Mariante RM; Silva AA; dos Santos AL; Roffê E; Santiago H; Gazzinelli RT; Lannes-Vieira J
PLoS One; 2015; 10(2):e0118600. PubMed ID: 25695249
[TBL] [Abstract][Full Text] [Related]
2. Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu.
Silva AA; Silva RR; Gibaldi D; Mariante RM; Dos Santos JB; Pereira IR; Moreira OC; Lannes-Vieira J
J Neuroinflammation; 2017 Sep; 14(1):182. PubMed ID: 28877735
[TBL] [Abstract][Full Text] [Related]
3. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
Front Immunol; 2020; 11():306. PubMed ID: 32194558
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
Millar AE; Kahn SJ
Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
[TBL] [Abstract][Full Text] [Related]
5. Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved.
Lannes-Vieira J; Vilar-Pereira G; Barrios LC; Silva AA
Mem Inst Oswaldo Cruz; 2023; 118():e220287. PubMed ID: 37018799
[TBL] [Abstract][Full Text] [Related]
6. Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-gamma and S100beta protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi.
Bombeiro AL; D'Império Lima MR; Chadi G; Alvarez JM
Neuroimmunomodulation; 2010; 17(2):67-78. PubMed ID: 19923851
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi.
Martins GA; Tadokoro CE; Silva RB; Silva JS; Rizzo LV
J Immunol; 2004 Apr; 172(8):4893-901. PubMed ID: 15067068
[TBL] [Abstract][Full Text] [Related]
8. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi evades the protective role of interferon-gamma-signaling in parasite-infected cells.
Stahl P; Ruppert V; Schwarz RT; Meyer T
PLoS One; 2014; 9(10):e110512. PubMed ID: 25340519
[TBL] [Abstract][Full Text] [Related]
10. Intracellular growth of Trypanosoma cruzi in cardiac myocytes is inhibited by cytokine-induced nitric oxide release.
Fichera LE; Albareda MC; Laucella SA; Postan M
Infect Immun; 2004 Jan; 72(1):359-63. PubMed ID: 14688116
[TBL] [Abstract][Full Text] [Related]
11. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruzi.
Vilar-Pereira G; Gibaldi D; Castaño-Barrios L; da Silva AA; Resende Pereira I; Cruz Moreira O; Britto C; Mata Dos Santos HA; de Oliveira Lopes R; Wanderley Tinoco L; Oliveira W; Lannes-Vieira J
PLoS Negl Trop Dis; 2024 May; 18(5):e0012199. PubMed ID: 38776344
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions.
Vilar-Pereira G; Silva AA; Pereira IR; Silva RR; Moreira OC; de Almeida LR; de Souza AS; Rocha MS; Lannes-Vieira J
Brain Behav Immun; 2012 Oct; 26(7):1136-49. PubMed ID: 22841695
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.
Pereira IR; Vilar-Pereira G; Silva AA; Moreira OC; Britto C; Sarmento ED; Lannes-Vieira J
Mediators Inflamm; 2014; 2014():798078. PubMed ID: 25140115
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.
Silva JS; Vespa GN; Cardoso MA; Aliberti JC; Cunha FQ
Infect Immun; 1995 Dec; 63(12):4862-7. PubMed ID: 7591147
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection.
Talvani A; Machado FS; Santana GC; Klein A; Barcelos L; Silva JS; Teixeira MM
Infect Immun; 2002 Aug; 70(8):4247-53. PubMed ID: 12117933
[TBL] [Abstract][Full Text] [Related]
18. The impairment in the NLRP3-induced NO secretion renders astrocytes highly permissive to T. cruzi replication.
Pacheco AL; Vicentini G; Matteucci KC; Ribeiro RR; Weinlich R; Bortoluci KR
J Leukoc Biol; 2019 Jul; 106(1):201-207. PubMed ID: 30997938
[TBL] [Abstract][Full Text] [Related]
19. Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression.
Guiñazú N; Pellegrini A; Carrera-Silva EA; Aoki MP; Cabanillas AM; Gìronés N; Fresno M; Cano R; Gea S
Int J Parasitol; 2007 Sep; 37(11):1243-54. PubMed ID: 17512528
[TBL] [Abstract][Full Text] [Related]
20. Interactions between local renin angiotensin system and nitric oxide in the brain of Trypanosoma cruzi infected rats.
Miranda AS; Rachid MA; Souza CF; Oliveira BDS; Ferreira RN; Martinelli PM; Teixeira AL; Camargos ERS; Simões E Silva AC
Acta Trop; 2019 Jun; 194():36-40. PubMed ID: 30898615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
